US · Healthcare

Rocket Pharmaceuticals, Inc. Warrant (RCKTW)

Biotechnology

Rocket Pharmaceuticals, Inc. Warrant (RCKTW) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Key metrics for RCKTW

P/E ratio
25.00

Rocket Pharmaceuticals, Inc. Warrant (RCKTW) — FAQ

What is RCKTW's P/E ratio?

The price-to-earnings (P/E) ratio for Rocket Pharmaceuticals, Inc. Warrant (RCKTW) is 25.00 (data as of 2026-05-23).

Does Rocket Pharmaceuticals, Inc. Warrant pay a dividend?

Dividend yield is not available in the current snapshot for Rocket Pharmaceuticals, Inc. Warrant (RCKTW). Check the MyAverix Finance app for the latest dividend data.

What sector is Rocket Pharmaceuticals, Inc. Warrant in?

Rocket Pharmaceuticals, Inc. Warrant (RCKTW) is classified in the Healthcare sector (Biotechnology industry).

What exchange is RCKTW listed on?

RCKTW is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

App Store Google Play